Literature DB >> 26763006

Improved survival of patients with colon cancer detected by screening colonoscopy.

Armin Wiegering1,2,3, Sabine Ackermann4, Johannes Riegel4, Ulrich A Dietz4, Oliver Götze5, Christoph-Thomas Germer4,6, Ingo Klein7,8,9.   

Abstract

BACKGROUND: Screening for colon cancer (CC) may not only reduce its occurrence but has also the potential to reduce the overall mortality. So far, there has been little evidence that detection of colon cancer by screening colonoscopy results in different survival rates compared to symptomatic patients. PATIENTS AND METHODS: Clinical, histological, diagnostic, and survival data of 1016 consecutive patients with CC from a prospectively expanded single-institutional database were analyzed for diagnostic, treatment, and prognostic factors. Findings were then stratified according to detection by screening colonoscopy vs. patients who became symptomatic prior to further diagnostic work-up.
RESULTS: 7.1 % of all patients were identified by screening colonoscopy for colon cancer. Screened patients were younger (68.2 vs. 64.8 years), had smaller T stage (p = 0.032), lower tumor stage (p = 0.009), and a tendency to less lymph node metastasis. Overall survival was superior in screened patients, and stage-specific survival showed a tendency to improved survival, which was not statistically significant. Furthermore, a higher percentage of screened patients underwent adjuvant chemotherapy (84.6 vs. 55.0 %, p = 0.032).
CONCLUSION: Survival outcome and enrollment in a multimodal treatment was higher in screening-detected patients compared to patients diagnosed after the onset of clinical symptoms. Besides a potential occurrence of lead time bias, these findings strongly support the need for continued improvement of screening programs and the recruitment of more patients for colorectal cancer screening.

Entities:  

Keywords:  Adenoma-carcinoma sequence; Colon cancer; Colonoscopy; Lead time bias; Surgery; Survival

Mesh:

Year:  2016        PMID: 26763006     DOI: 10.1007/s00384-015-2501-6

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  24 in total

1.  Colorectal-cancer incidence and mortality after screening.

Authors:  Reiko Nishihara; Shuji Ogino; Andrew T Chan
Journal:  N Engl J Med       Date:  2013-12-12       Impact factor: 91.245

2.  American Cancer Society guidelines for the early detection of cancer.

Authors:  Robert A Smith; Vilma Cokkinides; Andrew C von Eschenbach; Bernard Levin; Carmel Cohen; Carolyn D Runowicz; Stephen Sener; Debbie Saslow; Harmon J Eyre
Journal:  CA Cancer J Clin       Date:  2002 Jan-Feb       Impact factor: 508.702

Review 3.  DNA testing and molecular screening for colon cancer.

Authors:  John M Carethers
Journal:  Clin Gastroenterol Hepatol       Date:  2013-12-17       Impact factor: 11.382

4.  Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up.

Authors:  J H Scholefield; S M Moss; C M Mangham; D K Whynes; J D Hardcastle
Journal:  Gut       Date:  2011-11-03       Impact factor: 23.059

Review 5.  Pathology of the adenoma-carcinoma sequence: from aberrant crypt focus to invasive carcinoma.

Authors:  O W Cummings
Journal:  Semin Gastrointest Dis       Date:  2000-10

6.  Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study.

Authors:  Hermann Brenner; Anne Marie Bouvier; Roberto Foschi; Monika Hackl; Inger Kristin Larsen; Valery Lemmens; Lucia Mangone; Silvia Francisci
Journal:  Int J Cancer       Date:  2011-08-03       Impact factor: 7.396

7.  A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds.

Authors:  O D Jørgensen; O Kronborg; C Fenger
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

8.  Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study.

Authors:  Christine N Manser; Lucas M Bachmann; Jakob Brunner; Fritz Hunold; Peter Bauerfeind; Urs A Marbet
Journal:  Gastrointest Endosc       Date:  2012-04-11       Impact factor: 9.427

Review 9.  Barriers to cancer screening.

Authors:  R J Womeodu; J E Bailey
Journal:  Med Clin North Am       Date:  1996-01       Impact factor: 5.456

10.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.

Authors:  S J Winawer; A G Zauber; M N Ho; M J O'Brien; L S Gottlieb; S S Sternberg; J D Waye; M Schapiro; J H Bond; J F Panish
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

View more
  5 in total

1.  Colorectal cancer screening by colonoscopy and trends in disease-specific mortality: a population-based ecological study of 358 German districts.

Authors:  Joachim Hübner; Philip Lewin; Ron Pritzkuleit; Nora Eisemann; Werner Maier; Alexander Katalinic
Journal:  Int J Colorectal Dis       Date:  2019-01-10       Impact factor: 2.571

Review 2.  The gut microbiota and gastrointestinal surgery.

Authors:  Kristina Guyton; John C Alverdy
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-10-12       Impact factor: 46.802

Review 3.  Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor.

Authors:  Madelyn Espinosa-Cotton; Nai-Kong V Cheung
Journal:  Front Oncol       Date:  2021-11-19       Impact factor: 5.738

4.  Mailed fecal testing and patient navigation versus usual care to improve rates of colorectal cancer screening and follow-up colonoscopy in rural Medicaid enrollees: a cluster-randomized controlled trial.

Authors:  Gloria D Coronado; Michael C Leo; Katrina Ramsey; Jennifer Coury; Amanda F Petrik; Mary Patzel; Erin S Kenzie; Jamie H Thompson; Erik Brodt; Raj Mummadi; Nancy Elder; Melinda M Davis
Journal:  Implement Sci Commun       Date:  2022-04-13

Review 5.  [Impact of COVID-19 on elective and emergency colorectal surgery].

Authors:  Johan F Lock; Franziska Köhler; Christoph-Thomas Germer; Sven Flemming; Armin Wiegering
Journal:  Chirurg       Date:  2021-07-13       Impact factor: 0.955

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.